menu search

Schrödinger to present new preclinical data from its cdc7 inhibitor program at american society of hematology 2022 annual meeting

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and mate...

November 3, 2022, 9:23 am

Nuvalent to present preliminary phase 1 data from arros-1 clinical trial of nvl-520 at 34th eortc-nci-aacr symposium and announces pipeline updates

Preliminary Dose Escalation Data on ROS1-selective Inhibitor NVL-520 to be Presented in the "New Drugs on the Horizon" Oral Plenary Session New Pr...

September 7, 2022, 6:30 am

Tyra biosciences to present preclinical data on tyra-300, an fgfr3-selective inhibitor, at esmo 2022 congress

CARLSBAD, Calif. , Sept. 5, 2022 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision oncology company focused on developing purpose-bui...

September 5, 2022, 8:15 am

Vyant bio posts q2 results, set to advance vynt-0126 to treat rett syndrome into clinical trials early next year

Vyant Bio (NASDAQ:VYNT) Inc revealed that it is advancing its repurposed drug candidate, VYNT-0126 to treat Rett Syndrome, into clinical trials early ...

August 23, 2022, 7:07 am

Nuvalent to present new nvl-655 preclinical data and arros-1 trial in progress poster for nvl-520 at iaslc 2022 world conference on lung cancer annual meeting

Preclinical activity of ALK-selective inhibitor NVL-655 in a lorlatinib-resistant model of NSCLC with a...

July 13, 2022, 6:30 am

Hoth therapeutics shares surge on encouraging preclinical data from alzheimer's program

Hoth Therapeutics Inc (NASDAQ: HOTH) has announced proof-of-concept data generated using cognitive and behavioral assessments in an Alzheimer's dis...

July 12, 2022, 2:37 pm

Why aditxt shares are rallying today?

Aditxt Inc's (NASDAQ: ADTX) therapeutic program Adimune has completed a toxicology study indicating a favorable safety profile of ADI-100 for rejec...

July 8, 2022, 9:51 am

Betterlife pharma secures additional mitacs funding for betr-001 preclinical depression studies

BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) said it has secured additional Mitacs funding for preclinical<...

July 6, 2022, 8:44 am

Allergy therapeutics to present 18 posters at eaaci conference

Allergy Therapeutics said will present 18 posters and host two symposia at the European Academy of Allergy and Clinical Immunology (EAACI) 2022 this m...

July 1, 2022, 3:03 am

Pyxis oncology to present at h.c. wainwright preclinical cancer drug discovery conference

CAMBRIDGE, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), an oncology company focused on developing next-generation the...

June 28, 2022, 6:35 am

Sana biotechnology a buy for potential cancer therapies

Preclinical stage company has cash, expertise, and platform for success. Recent pr...

June 27, 2022, 2:21 am

Betterlife pharma to present betr-001 preclinical data at fens forum in paris, france in july

BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) has announced that an abstract covering the anti-depressant activity of its lead compound 2-bromo-LSD ...

June 21, 2022, 9:31 am

Hepion pharmaceuticals to present five posters at easl international liver congress™ 2022

- Hepion Represented as Authors in Preclinical and Clinical Posters Related to Rencofilstat and Cycloph...

June 15, 2022, 8:00 am

Hc wainwright sees this small-cap biotech as undervalued, underappreciated

At the European Hematology Association (EHA) meeting, Oncternal Therapeutics Inc (NASDAQ: ONCT) presented initial pr...

June 13, 2022, 11:21 am

Praxis: mdd trial failure may not mean an end to entire pipeline

A phase 2/3 trial failure in the MDD indication of PRAX-114 allows this biotech to shift focus over to PRAX-944 for Essential tremors and other pr...

June 10, 2022, 2:45 pm

Biomea fusion to present new preclinical data showing bmf-219's strong activity in relapsed/refractory chronic lymphocytic leukemia (cll) tumor models at asco 2022

REDWOOD CITY, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to dis...

May 26, 2022, 6:30 pm

Why shares of adaptimmune therapeutics rose 13.4% on tuesday

The clinical-stage biotech saw its shares rise after releasing preclinical data on two of its therapies...

May 17, 2022, 5:03 pm

Skye bioscience says study shows enhanced reduction in intraocular pressure with its sbi-100 formulation for glaucoma

Skye Bioscience inc (OTCQB:SKYE) announced that the peer-reviewed journal International Journal of Pharmaceutics has published pr...

May 5, 2022, 8:43 am

Betterlife to present betr-001 preclinical data at canadian association for neuroscience conference

BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) has announced that an abstract from the preclinical data...

April 21, 2022, 10:02 am

Hookipa shares jump on new preclinical data on cancer immunotherapies

HOOKIPA Pharma Inc (NASDAQ: HOOK) has announced preclinical data demonstrating potent T cell respons...

April 13, 2022, 11:52 am


Search within

Pages Search Results: